
Samsung Biologics launches record $1.8 billion bid for PolyPeptide, targeting obesity drug market
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxNZlEtRW1kakFGRU11Tmt2bHpNbEplMFRBN1JJbHRSaHMzUlN0SHZEaWx2N3Vnai1PWHNYbWQ4cEtSazNBSEhTVk9xQ1NoYlJFOXd6X1ZwOGF5XzJ0MDZ5NGlERmxvaVZVTU1WbmtNUTcxbjNWYnp4U3RyTGVzcV93aVNDLWRXVUFTOFRMRTdYbDNWbFBKUlJ3bzZPdWxmUV9WY0RDVHYyODlpRnZGU0xyajBkYjZ4OEZQWnh0bVdITy1UWmUtZzAzZUhqMUNFZ3Fxalg1YmFUekRQdHZPZlJ4aw?oc=5" target="_blank">Samsung Biologics launches record $1.8 billion bid for PolyPeptide, targeting obesity drug market</a>&nbsp;&nbsp;<font color="#6f6f6f">Korea JoongAng Daily</font>

